{
  "figure_1": "Relationships between the three traits examined in this study.",
  "figure_2": "Genetic correlations between body mass index (BMI), breast size and breast cancer risk (overall, ER-positive and ER-negative). Colour intensity indicates correlation strength, with red indicating positive correlation (from 0 to +1) and yellow indicating negative correlation (from 0 to −1). Significant relationships (P < 0.05) are denoted by asterisks.",
  "figure_3": "Odds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.",
  "figure_4": "Scatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.",
  "figure_5": "Leave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.",
  "figure_6": "Scatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.",
  "figure_7": "Leave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.",
  "figure_8": "Odds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.",
  "figure_10": "Leave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.",
  "figure_9": "Scatter plots of SNP-breast cancer risk associations against SNP-breast size associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.",
  "figure_11": "Relationships discovered in this study. Significant results from LDSC regression are denoted by dotted lines and significant results from MR analysis are denoted by solid arrows."
}